Cassell PLC - Rule 8 Disclosure
November 02 1998 - 6:25AM
UK Regulatory
RNS No 983q
CASSELL
Date of Disclosure.......2/11/98.........
DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3
OF THE CITY CODE ON TAKE-OVERS AND MERGERS
Date of dealing.......30/10/98......
Dealing in..........CASSELL................................(name of company)
(1) Class of securities (eg ordinary shares).....ORD 20P..................
(2) Amount bought Amount sold Price per unit
405,600 125P
(3) Resultant total of the same class owned or controlled
(and percentage of class).....................NIL.................. ( %)
(4) Party making disclosure.PHILLIPS AND DREW FUND MANAGEMENT LIMITED.......
(5) EITHER (a) Name of purchaser/vendor (Note 1).............................
OR (b) if dealing for discretionary client(s), name of fund management
organisation
.PHILLIPS AND DREW FUND MANAGEMENT LIMITED.....................................
(6) Reason for disclosure (Note 2)
(a) associate of (i) offeror (Note 3) NO
(ii) offeree company NO
Specify which category or categories of associate (1-8 overleaf)....N/A........
If category (8), explain.........N/A............................................
................................................................................
(b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more
of the class of relevant securities dealt in) YES
Signed, for and on behalf of the party named in (4) above......N/A..............
(Also print name of signatory)........J.D. ARDLEY...............................
Telephone and extension number........0171 901 5055............................
Note 1. Specify owner, not nominee or vehicle company. If relevant, also
identify controller of owner, eg where an owner normally acts on instructions of
a controller.
Note 2. Disclosure might be made for more than one reason; if so, state all
reasons.
Note 3. Specify which offeror if there is more than one.
Note 4. When an arrangement exists with any offeror, with the offeree company
or with an associate of any offeror or of the offeree company in relation to
relevant securities, details of such arrangement must be disclosed, as required
by Note 6 on Rule 8............................................................
...............................................................................
...............................................................................
For full details of disclosure requirements, see Rule 8 of the Code. If in
doubt, contact the Panel on Take-overs and Mergers, Tel. No: 0171-382 9026.
END
DCCUBGWUGBGRGGP
Cello Health (LSE:CLL)
Historical Stock Chart
From Sep 2024 to Oct 2024
Cello Health (LSE:CLL)
Historical Stock Chart
From Oct 2023 to Oct 2024